A 70-year-old client who is taking several cardiac antidysrhythmic medications has been prescribed simvastatin (Zocor) 80 mg/day. What is essential information for the nurse to teach the client?

Study for the NCLEX Pharmacology Cardiovascular Drugs Test. Explore multiple choice questions with detailed explanations and hints. Prepare confidently for your NCLEX exam!

Multiple Choice

A 70-year-old client who is taking several cardiac antidysrhythmic medications has been prescribed simvastatin (Zocor) 80 mg/day. What is essential information for the nurse to teach the client?

Explanation:
When a statin is used with several cardiac antidysrhythmic medications, the risk of muscle injury increases because these antidysrhythmics can raise statin blood levels by inhibiting the same metabolic pathways that clear statins. This is especially important in older adults on multiple meds, where polypharmacy already raises the chance of a harmful interaction. The essential concept is that higher statin exposure can lead to myopathy and, in more severe cases, rhabdomyolysis. Teach the client to watch for muscle pain, weakness, or dark urine and to report these symptoms promptly. The clinician may need to adjust the simvastatin dose or switch to a statin with fewer interactions, or choose a different cardiovascular plan altogether. Routine liver and muscle enzyme monitoring may be considered if symptoms occur or as part of ongoing care. Nurse should also emphasize that not every combination is an absolute contraindication, but significant interactions exist, and taking high-dose simvastatin (80 mg) with certain antidysrhythmic drugs markedly increases risk, so reporting symptoms and consulting the prescriber before continuing or altering therapy is essential.

When a statin is used with several cardiac antidysrhythmic medications, the risk of muscle injury increases because these antidysrhythmics can raise statin blood levels by inhibiting the same metabolic pathways that clear statins. This is especially important in older adults on multiple meds, where polypharmacy already raises the chance of a harmful interaction.

The essential concept is that higher statin exposure can lead to myopathy and, in more severe cases, rhabdomyolysis. Teach the client to watch for muscle pain, weakness, or dark urine and to report these symptoms promptly. The clinician may need to adjust the simvastatin dose or switch to a statin with fewer interactions, or choose a different cardiovascular plan altogether. Routine liver and muscle enzyme monitoring may be considered if symptoms occur or as part of ongoing care.

Nurse should also emphasize that not every combination is an absolute contraindication, but significant interactions exist, and taking high-dose simvastatin (80 mg) with certain antidysrhythmic drugs markedly increases risk, so reporting symptoms and consulting the prescriber before continuing or altering therapy is essential.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy